Characterizing DNA methylation alterations from The Cancer Genome Atlas
Open accessAbstract
The Cancer Genome Atlas (TCGA) Research Network is an ambitious multi-institutional consortium effort aimed at characterizing sequence, copy number, gene (mRNA) expression, microRNA expression, and DNA methylation alterations in 30 cancer types. TCGA data have become an extraordinary resource for basic, translational, and clinical researchers and have the potential to shape cancer diagnostic and treatment strategies. DNA methylation changes are integral to all aspects of cancer genomics and have been shown to have important associations with gene expression, sequence, and copy number changes. This Review highlights the knowledge gained from DNA methylation alterations in human cancers from TCGA.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · see citing works
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927 · see citing works
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735 · see citing works
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · see citing works
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · see citing works
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works
<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · see citing works
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648 · see citing works
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,610 · see citing works
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016 · see citing works
Self-citationHuman DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · see citing works
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994 · see citing works
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · see citing works
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451 · see citing works
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,506 · see citing works
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,430 · see citing works
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works
Self-citationControl of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,238 · see citing works
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177 · see citing works
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J. P., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990 · see citing works
Self-citationIDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works
High density DNA methylation array with single CpG site resolution
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., Schroth, G. P., Gunderson, K. L., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.007 · Cited by 1,727 · see citing works
Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Goldberg, A. D., Banaszynski, L. A., Noh, K., Lewis, P. W., Elsässer, S. J., Stadler, S. C., Dewell, S. B., Law, M. J., Guo, X., Li, X., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.003 · Cited by 1,281 · see citing works
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · see citing works
Hartmann, C. J., Meyer, J., Balß, J., Capper, D., Mueller, W. C., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163 · see citing works
DNA methylation and gene silencing in cancer
Baylin, S. B. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0354 · Cited by 1,156 · see citing works
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143 · see citing works
Self-citationOhm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130 · see citing works
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Suzuki, H., Watkins, D. N., Jair, K.-W., Schuebel, K. E., Markowitz, S. D., Chen, W. D., Pretlow, T. P., Yang, B., Akiyama, Y., van Engeland, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1330 · Cited by 1,070 · see citing works
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D. H., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,053 · see citing works
Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
Ehrlich, M., Gama-Sosa, M. A., Huang, L.-H., Midgett, R. M., Kuo, K. C., McCune, R. A., & Gehrke, C. W. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.8.2709 · Cited by 1,039 · see citing works
Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution
Booth, M. J., Branco, M. R., Ficz, G., Oxley, D., Krueger, F., Reik, W., & Balasubramanian, S. (2012) · Science · doi:10.1126/science.1220671 · Cited by 923 · see citing works
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 912 · see citing works
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · see citing works
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Kickhoefer, V. A., Trewyn, R. W., Oxenhandler, R. W., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 846 · see citing works
Jones, R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg962 · Cited by 828 · see citing works
Paschka, P., Schlenk, R. F., Gaidzik, V. I., Habdank, M., Krönke, J., Bullinger, L., Späth, D., Käyser, S., Zucknick, M., Götze, K. S. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3762 · Cited by 803 · see citing works
Marcucci, G., Maharry, K. S., Wu, Y.-Z., Radmacher, M. D., Mrózek, K., Margeson, D., Holland, K. B., Whitman, S. P., Becker, H., Schwind, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3730 · Cited by 763 · see citing works
5-Methylcytosine in Eukaryotic DNA
Ehrlich, M., & Wang, R. Y. ‐. (1981) · Science · doi:10.1126/science.6262918 · Cited by 745 · see citing works
Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736 · see citing works
Temozolomide and treatment of malignant glioma.
Friedman, H. S., Kerby, T., & Calvert, H. (2000) · PubMed · Cited by 722 · see citing works
A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA
Bird, A. P., Taggart, M. H., Frommer, M., Miller, O. J., & Macleod, D. (1985) · Cell · doi:10.1016/0092-8674(85)90312-5 · Cited by 714 · see citing works
Analysis of repetitive element DNA methylation by MethyLight
Weisenberger, D. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki987 · Cited by 708 · see citing works
Self-citationBerman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., Noushmehr, H., Lange, C. P. E., van Dijk, C. M., Tollenaar, R. A. E. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.969 · Cited by 660 · see citing works
Self-citationLovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629 · cited 1× · see citing works
“ATRX mutations are predominant in the alternative lengthening of telomeres (ALT), a process by which telomere length is maintained independent of telomerase in cancer cells (48, 49).”
IDH1 and IDH2 mutations in gliomas
Cohen, A. L., Holmen, S. L., & Colman, H. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0345-4 · Cited by 629 · see citing works
Genome-scale analysis of aberrant DNA methylation in colorectal cancerPreprint
Hinoue, T., Weisenberger, D. J., Lange, C., Shen, H., Byun, H., Van, D., Malik, S., Pan, F., Noushmehr, H., van, C., et al. (2011) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 604 · see citing works
Self-citationYang, D., Khan, S., Sun, Y., Hess, K., Shmulevich, I., Sood, A. K., & Zhang, W. (2011) · JAMA · doi:10.1001/jama.2011.1456 · Cited by 599 · see citing works
Genome-Wide Dna Methylation Profiling Using Infinium ® Assay
Bibikova, M. V., Le, J. M., Barnes, B., Saedinia-Melnyk, S., Zhou, L., Shen, R., & Gunderson, K. L. (2009) · Epigenomics · doi:10.2217/epi.09.14 · Cited by 592 · see citing works
Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., Valsesia, A., Ye, Z., Kuan, S., Edsall, L. E., et al. (2012) · Genome Research · doi:10.1101/gr.125872.111 · Cited by 583 · see citing works
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E. H., Zhang, L., Guo, Y., Hernandez, N., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 556 · see citing works
Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming
Song, C., Szulwach, K. E., Dai, Q., Fu, Y., Mao, S.-Q., Lin, L., Street, C., Li, Y., Poidevin, M., Wu, H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.001 · Cited by 545 · see citing works
Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics
Shen, L., Wu, H., Diep, D., Yamaguchi, S., D’Alessio, A. C., Fung, H.-L., Zhang, K., & Zhang, Y. (2013) · Cell · doi:10.1016/j.cell.2013.04.002 · Cited by 497 · see citing works
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484 · see citing works
Spatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes
Bannister, A. J., Schneider, R., Myers, F. A., Thorne, A. W., Crane‐Robinson, C., & Kouzarides, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500796200 · Cited by 459 · see citing works
IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Yang, H., Ye, D., Guan, K., & Xiong, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1773 · Cited by 459 · see citing works
Tefferi, A., Lasho, T. L., Abdel-Wahab, O. I., Guglielmelli, P., Patel, J. L., Caramazza, D., Pieri, L., Finke, C. M., Kilpivaara, O., Wadleigh, M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.113 · Cited by 317 · see citing works
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M. F., & Fuchs, C. S. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 293 · see citing works
Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang, F., Turcan, Ş., Rimner, A., Kaufman, A., Giri, D. D., Morris, L. G. T., Shen, R., Seshan, V., Mo, Q., Heguy, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001875 · Cited by 267 · see citing works
Wagner, K., Damm, F., Göhring, G., Görlich, K., Heuser, M., Schäfer, I., Ottmann, O. G., Lübbert, M., Heit, W. F. W., Kanz, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6899 · Cited by 241 · see citing works
Raiber, E., Beraldi, D., Ficz, G., Burgess, H. E., Branco, M. R., Murat, P., Oxley, D., Booth, M. J., Reik, W., & Balasubramanian, S. (2012) · Genome biology · doi:10.1186/gb-2012-13-8-r69 · Cited by 230 · see citing works
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Yagi, K., Akagi, K., Hayashi, H., Nagae, G., Tsuji, S., Isagawa, T., Midorikawa, Y., Nishimura, Y., Sakamoto, H., Seto, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2006 · Cited by 223 · see citing works
Inactivation of BRCA1 and BRCA2 in Ovarian Cancer
Hilton, J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.18.1396 · Cited by 218 · see citing works
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylationPreprint
Duncan, C. G., Barwick, B. G., Jin, G., Rago, C., Kapoor-Vazirani, P., Powell, D. R., Chi, J., Bigner, D. D., Vertino, P. M., & Yan, H. (2012) · Genome Research · doi:10.1101/gr.132738.111 · Cited by 176 · see citing works
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Guilhamon, P., Eskandarpour, M., Halai, D., Wilson, G. A., Feber, A., Teschendorff, A. E., Gómez, V., Hergovich, A., Tirabosco, R., Amary, F. M., et al. (2013) · Nature Communications · doi:10.1038/ncomms3166 · Cited by 169 · see citing works
Hashimoto, H., Hong, S., Bhagwat, A. S., Zhang, X., & Cheng, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks845 · Cited by 147 · see citing works
GoldenGate® Assay for DNA Methylation Profiling
Bibikova, M. V., & Fan, J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-522-0_12 · Cited by 145 · see citing works
Splicing into Senescence: The Curious Case of p16 and p19ARF
Haber, D. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80441-9 · Cited by 144 · see citing works
Hinoue, T., Weisenberger, D. J., Pan, F., Campan, M., Kim, M.-J., Young, J. P., Whitehall, V., Leggett, B., & Laird, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008357 · Cited by 144 · see citing works
Self-citationIDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo
Bralten, L. B. C., Kloosterhof, N. K., Balvers, R. K., Sacchetti, A., Lapre, L., Lamfers, M. L. M., Leenstra, S., de Jonge, H. R., Kros, J. M., Jansen, E. E. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22390 · Cited by 141 · see citing works
Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
Jin, G., Reitman, Z. J., Duncan, C. G., Spasojević, I., Gooden, D. M., Rasheed, B. A., Yang, R. R., Lopez, G. Y., He, Y., McLendon, R. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2852 · Cited by 124 · see citing works
Chantalat, S., Depaux, A., Héry, P., Barral, S., Thuret, J., Dimitrov, S. I., & Gérard, M. (2011) · Genome Research · doi:10.1101/gr.118091.110 · Cited by 119 · see citing works
Jin, G., Reitman, Z. J., Spasojevic, I., Batinic-Haberle, I., Yang, J., Schmidt-Kittler, O., Bigner, D. D., & Yan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016812 · Cited by 112 · see citing works
Whitcomb, B. P., Mutch, D. G., Herzog, T. J., Rader, J. S., Gibb, R. K., & Goodfellow, P. J. (2003) · PubMed · Cited by 104 · see citing works
Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G. J., Loda, M. F., & Fuchs, C. S. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.018 · Cited by 67 · see citing works
Diala, E. S., & Hoffman, R. M. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91663-1 · Cited by 46 · see citing works
Increased levels of 2‐hydroxyglutarate in AML patients with IDH1‐R132H and IDH2‐R140Q mutations
Sellner, L., Capper, D., Meyer, J., Langhans, C., Hartog, C.-M., Pfeifer, H., Serve, H. L., Ho, A. D., Okun, J. G., Krämer, A., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01505.x · Cited by 43 · see citing works
DNA methylation levels in normal and chemically-transformed mouse 3T3 cells
Diala, E. S., & Hoffman, R. M. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91419-x · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 90 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Paschka P, et al. IDH1 and IDH2 mutations are fre- quent genetic alterations in acute myeloid leuke- mia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 muta- tion without FLT3 internal tandem duplication. J Clin Oncol. 2010;28(22):3636-3643.
Cited by
Sorted by citations
Moss, J., Magenheim, J., Neiman, D., Zemmour, H., Loyfer, N., Korach, A., Samet, Y., Maoz, M., Druid, H., Arner, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07466-6 · Cited by 1,023 · see citing works
Morán, S., Arribas, C., & Esteller, M. (2015) · Epigenomics · doi:10.2217/epi.15.114 · Cited by 701 · see citing works
A DNA methylation atlas of normal human cell types
Loyfer, N., Magenheim, J., Peretz, A., Cann, G., Bredno, J., Klochendler, A., Fox-Fisher, I., Shabi-Porat, S., Hecht, M., Pelet, T., et al. (2023) · Nature · doi:10.1038/s41586-022-05580-6 · Cited by 656 · see citing works
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Chen, X., Gole, J., Gore, A., He, Q., Lü, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 637 · see citing works
Comprehensive analysis of DNA methylation data with RnBeads
Assenov, Y., Müller, F., Lutsik, P., Walter, J., Lengauer, T., & Bock, C. (2014) · Nature Methods · doi:10.1038/nmeth.3115 · Cited by 587 · see citing works
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Malta, T. M., de Souza, C. F., Sabedot, T. S., Silva, T. C., Mosella, M. S., Kalkanis, S. N., Snyder, J., Castro, A. V. B., & Noushmehr, H. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox183 · Cited by 302 · see citing works
The Role of DNA Methylation in Cancer
Lakshminarasimhan, R., & Liang, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_7 · Cited by 267 · see citing works
Poornima, P., Kumar, J. D., Zhao, Q., Blunder, M., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.018 · Cited by 252 · see citing works
An EMT‐related gene signature for the prognosis of human bladder cancer
Cao, R., Yuan, L., Ma, B., Wang, G., Qiu, W., & Tian, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14767 · Cited by 187 · see citing works
Mattox, A. K., Douville, C. B., Wang, Y., Popoli, M., Ptak, J., Silliman, N., Dobbyn, L., Schaefer, J., Lu, S., Pearlman, A. H., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1252 · Cited by 166 · see citing works
Genetic and epigenetic factors determining NAFLD risk
Jonas, W., & Schürmann, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101111 · Cited by 157 · see citing works
TCGA Expedition: A Data Acquisition and Management System for TCGA Data
Chandran, U. R., Medvedeva, O. P., Barmada, M. M., Blood, P. D., Chakka, A. B., Luthra, S., Ferreira, A. M., Wong, K. F., Lee, A. V., Zhang, Z., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165395 · Cited by 112 · see citing works
Noguera‐Castells, A., García-Prieto, C. A., Álvarez‐Errico, D., & Esteller, M. (2023) · Epigenetics · doi:10.1080/15592294.2023.2185742 · Cited by 106 · see citing works
The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process
Wu, C., Wang, H., Ling, S., & Lu, X. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054842 · Cited by 102 · see citing works
Li, L., & Sun, Y. (2024) · MedComm · doi:10.1002/mco2.766 · Cited by 106 · see citing works
Genomic insights into head and neck cancer
Beck, T. N., & Golemis, E. A. (2016) · Cancers of the Head & Neck · doi:10.1186/s41199-016-0003-z · Cited by 97 · see citing works
Stolfa, G., Smonskey, M. T., Boniface, R., Hachmann, A., Gulde, P., Joshi, A. D., Pierce, A. P., Jacobia, S. J., & Campbell, A. (2018) · Biotechnology Journal · doi:10.1002/biot.201700227 · Cited by 97 · see citing works
Sheng, J., Shi, W., Guo, H., Long, W., Wang, Y., Qi, J., Liu, J., & Xu, Y. (2019) · Molecules · doi:10.3390/molecules24162899 · Cited by 95 · see citing works
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Brennan, K., Shin, J. H., Tay, J. K., Prunello, M., Gentles, A. J., Sunwoo, J. B., & Gevaert, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-17298-x · Cited by 92 · see citing works
Cao, T., Pan, W., Sun, X., & Shen, H. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0575-4 · Cited by 85 · see citing works
Epigenetic modifications in prostate cancer
Sugiura, M., Sato, H., Kanesaka, M., Imamura, Y., Sakamoto, S., Ichikawa, T., & Kaneda, A. (2020) · International Journal of Urology · doi:10.1111/iju.14406 · Cited by 83 · see citing works
Gupta, S. K., Smith, E. J., Mladek, A. C., Tian, S., Decker, P. A., Kizilbash, S. H., Kitange, G. J., & Sarkaria, J. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00670 · Cited by 81 · see citing works
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
Daskalakis, M., Brocks, D., Sheng, Y.-H., Islam, S., Ressnerova, A., Assenov, Y., Milde, T., Oehme, I., Witt, O., Goyal, A., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442623 · Cited by 81 · see citing works
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83 · see citing works
“DNA methylation alterations are essential to all phases of cancer genomics, and hypomethylation has been revealed to be pivotal in cancer progression [22].”
BackgroundDevelopment and validation of a CIMP-associated prognostic model for hepatocellular carcinoma
Li, G., Xu, W., Zhang, L., Liu, T., Jin, G.-N., Song, J., Wu, J., Wang, Y., Chen, W., Zhang, C., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.064 · Cited by 76 · see citing works
Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation
Pop, S., Enciu, A., Ţârcomnicu, I., Gille, E., & Tănase, C. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09627-x · Cited by 73 · see citing works
Neupane, M., Clark, A. P., Landini, S., Birkbak, N. J., Eklund, A. C., Lim, E., Culhane, A. C., Barry, W. T., Schumacher, S. E., Beroukhim, R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0341 · Cited by 72 · see citing works
Patterns of Chromosomal Aberrations in Solid Tumors
Grade, M., Difilippantonio, M. J., & Camps, J. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_6 · Cited by 64 · see citing works
Nuclear Phosphoinositides: Their Regulation and Roles in Nuclear Functions
Fiume, R., Faenza, I., Sheth, B., Poli, A., Vidalle, M. C., Mazzetti, C., Abdul, S. H., Campagnoli, F., Fabbrini, M., Kimber, S. T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122991 · Cited by 63 · see citing works
Epigenetic biomarkers in the blood of patients with urological malignancies
Ellinger, J., Müller, S. C., & Dietrich, D. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1019477 · Cited by 61 · see citing works
Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity
Das, P., & Taube, J. H. (2020) · Cancers · doi:10.3390/cancers12102792 · Cited by 57 · see citing works
PIP4K and the role of nuclear phosphoinositides in tumour suppression
Fiume, R., Bultsma, Y., Shah, Z. H., Keune, W., Jones, D. R., Jude, J., & Divecha, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.014 · Cited by 59 · see citing works
Mitchell, S. M., Ho, T., Brown, G. S., Baker, R. T., THOMAS, M. L., McEvoy, A., Xu, Z., Ross, J. P., Lockett, T. J., Young, G. P., et al. (2016) · Genes · doi:10.3390/genes7120125 · Cited by 59 · see citing works
Zhu, C., Utsunomiya, T., Ikemoto, T., Yamada, S., Morine, Y., Imura, S., Arakawa, Y., Takasu, C., Ishikawa, D., Imoto, I., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3874-4 · Cited by 58 · see citing works
Murray, D. H., Symonds, E. L., Young, G. P., Byrne, S. E., Rabbitt, P., Roy, A. C., Cornthwaite, K. J., Karapetis, C. S., & Pedersen, S. K. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2701-x · Cited by 58 · see citing works
Nakauchi, Y., Azizi, A., Thomas, D., Corces, M. R., Reinisch, A., Sharma, R., Hernandez, D. C., Köhnke, T., Karigane, D., Fan, A. C., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0143 · Cited by 55 · see citing works
Identification of hub genes and key pathways associated with the progression of gynecological cancer
Zhang, X., & Wang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.11004 · Cited by 52 · see citing works
Sánchez-Vega, F., Gotea, V., Margolin, G., & Elnitski, L. L. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0007-7 · Cited by 52 · see citing works
Clinical protein science in translational medicine targeting malignant melanoma
Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09468-6 · Cited by 45 · see citing works
Margolin, G., Petrykowska, H. M., Jameel, N., Bell, D. W., Young, A., & Elnitski, L. L. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.11.004 · Cited by 45 · see citing works
At the tipping point for epigenetic therapies in cancer
Jones, P. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74145 · Cited by 44 · see citing works
Pan, S.-J., Zhan, S.-K., Ji, W.-Z., Pan, Y., Liu, W. X., Li, D.-Y., Huang, P., Zhang, X.-X., Cao, C.-Y., Zhang, J., et al. (2015) · Scientific Reports · doi:10.1038/srep11066 · Cited by 43 · see citing works
Herrgott, G. A., Snyder, J. M., She, R., Malta, T. M., Sabedot, T. S., Lee, I. Y., Pawloski, J., Gondim, G. G. P., Asmaro, K. P., Zhang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41434-z · Cited by 42 · see citing works
Self-citationNakagawa, T., Matsusaka, K., Misawa, K., Ota, S., Takane, K., Fukuyo, M., Rahmutulla, B., Shinohara, K., Kunii, N., Sakurai, D., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.008 · Cited by 42 · see citing works
Miyata, T., Sonoda, K., Tomikawa, J., Tayama, C., Okamura, K., Maehara, K., Kobayashi, H., Wake, N., Kato, K., Hata, K., et al. (2015) · Sarcoma · doi:10.1155/2015/412068 · Cited by 39 · see citing works
Olkhov‐Mitsel, E., Savio, A. J., Kron, K. J., Pethe, V. V., Hermanns, T., Fleshner, N. E., van Rhijn, B. W., van der Kwast, T., Zlotta, A. R., & Bapat, B. V. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.001 · Cited by 39 · see citing works
Wang, Y., Li, G., Mao, F., Li, X., Liu, Q., Chen, L., Lv, L., Wang, X., Wu, J., Dai, W., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527671 · Cited by 38 · see citing works
Integrated analysis of the E2F transcription factors across cancer types
Wang, H., Wang, X., Xu, L., Zhang, J., & Cao, H. (2020) · Oncology Reports · doi:10.3892/or.2020.7504 · Cited by 39 · see citing works
Becket, E., Chopra, S. S., Duymich, C. E., Lin, J. J., You, J. S., Pandiyan, K., Nichols, P. W., Siegmund, K. D., Charlet, J., Weisenberger, D. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2622 · Cited by 37 · see citing works
Self-citationDNA Methylation in Urothelial Carcinoma
Schulz, W. A., & Goering, W. (2016) · Epigenomics · doi:10.2217/epi-2016-0064 · Cited by 35 · see citing works
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
Saluja, H., Karapetis, C. S., Pedersen, S. K., Young, G. P., & Symonds, E. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00275 · Cited by 35 · see citing works
The role of DNA methylation and hydroxymethylation in immunosenescence
Johnson, N. D., & Conneely, K. N. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.011 · Cited by 35 · see citing works
Young, G. P., Symonds, E. L., Nielsen, H. J., Ferm, L., Christensen, I. J., Dekker, E., Vlugt, M. V., Mallant–Hent, R. C., Boulter, N. R., Yu, B., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-020-00999-y · Cited by 32 · see citing works
Symonds, E. L., Pedersen, S. K., Yeo, B. S., Naji, H. A., Byrne, S. E., Roy, A. C., & Young, G. P. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13178 · Cited by 33 · see citing works
New Progress of Epigenetic Biomarkers in Urological Cancer
Wu, P., Cao, Z., & Wu, S. (2016) · Disease Markers · doi:10.1155/2016/9864047 · Cited by 32 · see citing works
Hata, A., Nakajima, T., Matsusaka, K., Fukuyo, M., Morimoto, J., Yamamoto, T., Sakairi, Y., Rahmutulla, B., Ota, S., Wada, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32532 · Cited by 32 · see citing works
The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation
Miller, B., Sánchez-Vega, F., & Elnitski, L. L. (2016) · Biomolecules · doi:10.3390/biom6040045 · Cited by 32 · see citing works
Cell‑free DNA as a liquid biopsy for early detection of gastric cancer (Review)
Huang, Z., Zhang, H., Yu, B. P., & Yu, D.-H. (2020) · Oncology Letters · doi:10.3892/ol.2020.12264 · Cited by 32 · see citing works
Włodarczyk, M., Ciebiera, M., Nowicka, G., Łoziński, T., Ali, M. K., & Al-Hendy, A. A. (2024) · Nutrients · doi:10.3390/nu16040559 · Cited by 31 · see citing works
CHST11 gene expression and DNA methylation in breast cancer
Herman, D., Leakey, T. I., Behrens, A. W., Yao‐Borengasser, A., Cooney, C. A., Jousheghany, F., Phanavanh, B., Siegel, E. R., Safar, A. M., Korourian, S., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2828 · Cited by 30 · see citing works
Prognostic significance of age related genes in patients with lower grade glioma
Wang, H., Wang, X., Xu, L., Zhang, J., & Cao, H. (2020) · Journal of Cancer · doi:10.7150/jca.41123 · Cited by 30 · see citing works
DNA Methylation and HPV-Associated Head and Neck Cancer
Nakagawa, T., Kurokawa, T., Mima, M., Imamoto, S., Mizokami, H., Kondo, S., Okamoto, Y., Misawa, K., Hanazawa, T., & Kaneda, A. (2021) · Microorganisms · doi:10.3390/microorganisms9040801 · Cited by 30 · see citing works
Terranova, C. J., Tang, M., Maitituoheti, M., Raman, A. T., Ghosh, A. K., Schulz, J., Amin, S. B., Orouji, E., Tomczak, K. J., Sarkar, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109410 · Cited by 30 · see citing works
Hopp, L., Loeffler‐Wirth, H., Galle, J., & Binder, H. (2018) · Epigenomics · doi:10.2217/epi-2017-0140 · Cited by 30 · see citing works
CpG Island Methylator Phenotype—A Hope for the Future or a Road to Nowhere?
Karpiński, P., & Sasiadek, M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020830 · Cited by 28 · see citing works
The methylome and cell-free DNA: current applications in medicine and pediatric disease
Spector, B. L., Harrell, L., Sante, D., Wyckoff, G. J., & Willig, L. K. (2023) · Pediatric Research · doi:10.1038/s41390-022-02448-3 · Cited by 29 · see citing works
Pisanic, T. R., Athamanolap, P., & Wang, T. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.030 · Cited by 27 · see citing works
Iida, N., Okuda, Y., Ogasawara, O., Yamashita, S., Takeshima, H., & Ushijima, T. (2018) · Epigenomics · doi:10.2217/epi-2017-0093 · Cited by 28 · see citing works
Investigating the DNA methylation profile of e-cigarette use
Richmond, R. C., Rejon, C. S., Khouja, J. N., Prince, C., Alexander Board, Sharp, G. C., Suderman, M. J., Relton, C. L., Munafo, M. R., & Gage, S. H. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01174-7 · Cited by 27 · see citing works
Genome-Wide Epigenetic Studies in Human Disease: A Primer on -Omic Technologies
Yan, H., Tian, S., Slager, S. L., Sun, Z., & Ördög, T. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv187 · Cited by 26 · see citing works
Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies
Magenheim, J., Rokach, A., Peretz, A., Loyfer, N., Cann, G. M., Amini, H., Moradi, P. W., Nagaraju, S., Sameer, W., Cohen, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.03056-2021 · Cited by 23 · see citing works
Janke, F., Angeles, A. K., Riediger, A. L., Bauer, S., Reck, M., Stenzinger, A., Schneider, M. A., Muley, T., Thomas, M., Christopoulos, P., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01387-4 · Cited by 26 · see citing works
Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer
Wang, F., Ma, Y., Wang, H., & Qin, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.5593 · Cited by 25 · see citing works
The Role of DNA Methylation and DNA Methyltransferases in Cancer
Weisenberger, D. J., Lakshminarasimhan, R., & Liang, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_13 · Cited by 27 · see citing works
Self-citationZhang, Y., Delahanty, R., Guo, X., Zheng, W., & Long, J. (2015) · Human Genomics · doi:10.1186/s40246-015-0056-9 · Cited by 25 · see citing works
Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis
Soliman, S. H. A., Orlacchio, A., & Verginelli, F. (2021) · Microorganisms · doi:10.3390/microorganisms9061179 · Cited by 24 · see citing works
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
Huertas-Martínez, J., Rello‐Varona, S., Herrero‐Martín, D., Barrau, I., García-Monclús, S., Sáinz‐Jaspeado, M., Lagares‐Tena, L., Núñez‐Álvarez, Y., Mateo‐Lozano, S., Mora, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2403 · Cited by 23 · see citing works
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
Li, J. M., Zhang, D., Zhu, J., & Dong, L. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03209-4 · Cited by 24 · see citing works
Drury, J. L., & Chung, W. O. (2014) · Pathogens and Disease · doi:10.1093/femspd/ftu005 · Cited by 23 · see citing works
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis
Langstein, J., Milsom, M. D., & Lipka, D. B. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.09.008 · Cited by 23 · see citing works
Zampini, M., Tregnago, C., Bisio, V., Simula, L., Borella, G., Manara, E., Zanon, C., Zonta, F., Serafin, V., Accordi, B., et al. (2018) · Leukemia · doi:10.1038/s41375-017-0003-y · Cited by 23 · see citing works
SOX14 hypermethylation as a tumour biomarker in cervical cancer
Zhao, J. T., Cao, H., Zhang, W., Yongjuan, F., Shi, S., & Wang, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08406-2 · Cited by 22 · see citing works
Pedersen, S. K., Symonds, E. L., Roy, A. C., Cornthwaite, K. J., LaPointe, L. C., & Young, G. P. (2022) · Cancer Medicine · doi:10.1002/cam4.5008 · Cited by 21 · see citing works
Shin, J., Bourdon, C., Bernard, M., Wilson, M. D., Reischl, E., Waldenberger, M., Ruggeri, B., Schumann, G., Desrivières, S., Leemans, A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv294 · Cited by 20 · see citing works
Pancreatic cancer heterogeneity and response to Mek inhibition
Pedersen, K., Bilal, F., Morales, C. B., Salcedo, M., Macarulla, T. M., Massó-Vallés, D., Mohan, V., Vivancos, A. P., Carreras, M.-J., Serres, X., et al. (2017) · Oncogene · doi:10.1038/onc.2017.174 · Cited by 22 · see citing works
Chen, C., Gao, D., Huo, J., Qu, R., Guo, Y., Hu, X., & Luo, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-91290-4 · Cited by 22 · see citing works
Tian, Z., Meng, L., Long, X., Diao, T., Hu, M., Wang, M., Liu, M., & Wang, J. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01345-1 · Cited by 21 · see citing works
Luo, W., Wang, Z., & Zhang, X. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0547-6 · Cited by 21 · see citing works
Karpiński, P., Pesz, K. A., & Sasiadek, M. M. (2017) · Epigenomics · doi:10.2217/epi-2017-0070 · Cited by 20 · see citing works
Pedersen, S. K., Musher, B., LaPointe, L. C., Tuck, M. K., Symonds, E. L., Loayza, N., & Young, G. P. (2022) · Cancer · doi:10.1002/cncr.34159 · Cited by 19 · see citing works
Wang, Y., Zhang, L., Chen, Y., Li, M., Min-wen, H., & Li, S. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23450 · Cited by 19 · see citing works
Aberrant methylation patterns in colorectal cancer: a meta-analysis
Durso, D. F., Bacalini, M. G., do Valle, Í. F., Pirazzini, C., Bonafè, M., Castellani, G., Faria, A. M. C., Franceschi, C., Garagnani, P., & Nardini, C. (2017) · Oncotarget · doi:10.18632/oncotarget.14590 · Cited by 19 · see citing works
Wang, Z., He, Z., Lin, R., Feng, Z., Li, X., Sui, X., Gu, L., Xia, T., Zhou, D., Zhao, B., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03662-y · Cited by 19 · see citing works
Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes
Khan, R., Puszyński, K., & Kozłowska, E. (2024) · Genes · doi:10.3390/genes15050577 · Cited by 18 · see citing works
Clinical Genomics: Challenges and Opportunities
Vijay, P., McIntyre, A. B. R., Mason, C. E., Greenfield, J. P., & Li, S. (2016) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2016015724 · Cited by 18 · see citing works
Murray, D. H., Baker, R. T., Gaur, S., Young, G. P., & Pedersen, S. K. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.023135 · Cited by 19 · see citing works
Analysis of methylation microarray for tissue specific detection
Muangsub, T., Samsuwan, J., Tongyoo, P., Kitkumthorn, N., & Mutirangura, A. (2014) · Gene · doi:10.1016/j.gene.2014.09.060 · Cited by 17 · see citing works
Compartmentation of Metabolites in Regulating Epigenomes of Cancer
Zhao, Z., Wang, L., & Di, L. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00051 · Cited by 17 · see citing works
Great expectations – Epigenetics and the meandering path from bench to bedside
Häfner, S. J., & Lund, A. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.01.008 · Cited by 17 · see citing works
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis
Selman, M., Buendia-Roldan, I., & Pardo, A. (2025) · European Respiratory Journal · doi:10.1183/13993003.02418-2024 · Cited by 16 · see citing works
- Authors
- Weisenberger, D. J.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Weisenberger, Daniel J.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-01-02
- Volume
- 124
- Issue
- 1
- Pages
- 17-23
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3871233
- OpenAlex
- W2132035843
- Cited by
- 200
- References
- 90
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 15 · 2023: 11 · 2022: 17 · 2021: 24 · 2020: 18 · 2019: 15 · 2018: 14 · 2017: 22 · 2016: 19 · 2015: 20 · 2014: 12
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Southern California
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA methylation, epigenetic modifications, cancer genomics, TCGA, cancer types, gene expression, copy number alterations, microRNA expression, cancer diagnosis, cancer therapy
- MeSH terms
- Animals, Chromatin, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasms, DNA Modification Methylases, Genome, Human, DNA Methylation, BRCA1 Protein, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Epigenesis, Genetic, DNA Repair Enzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review